BeiGene Ltd. ADR (BGNE) Social Stream



BeiGene Ltd. ADR (BGNE): $190.38

0.20 (-0.10%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

D

Add BGNE to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#164 of 360

in industry

BEIGENE LTD (BGNE) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering BGNE.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-08 5 $431 $343.3 $404.46 $187.78 115.39%
2022-01-06 6 $431 $283.3 $392.46 $187.78 109%
2022-01-12 6 $431 $283.3 $388.716 $187.78 107.01%
2022-01-18 6 $431 $283.3 $380.883 $187.78 102.83%
2022-01-28 6 $431 $283.3 $367.55 $187.78 95.73%
2022-02-08 6 $431 $283.3 $354.216 $187.78 88.63%
2022-02-25 6 $431 $283.3 $348.55 $187.78 85.62%
2022-02-28 6 $431 $254 $332.333 $187.78 76.98%
2022-03-17 6 $431 $177 $300.2 $187.78 59.87%
2022-04-28 6 $431 $177 $313.166 $187.78 66.77%
2022-05-06 6 $431 $177 $296.166 $187.78 57.72%
2022-05-18 6 $431 $177 $289.833 $187.78 54.35%
2022-07-27 6 $431 $177 $288.666 $187.78 53.73%
2022-08-05 6 $431 $177 $284.316 $187.78 51.41%
2022-08-09 6 $431 $177 $271.983 $187.78 44.84%
2022-09-17 6 $431 $177 $270.6 $187.78 44.1%
2022-10-03 6 $431 $177 $269.433 $187.78 43.48%
2022-10-13 6 $296 $200 $236.433 $187.78 25.91%
2022-11-14 6 $296 $205 $240.266 $187.78 27.95%
2022-12-12 7 $296 $205 $244.6 $187.78 30.26%
2022-12-15 6 $302 $205 $245.6 $187.78 30.79%
2023-01-19 6 $302 $205 $256.266 $187.78 36.47%
2023-01-24 6 $325 $205 $261.266 $187.78 39.13%
2023-02-07 7 $325 $205 $261.266 $187.78 39.13%
2023-02-20 7 $325 $205 $266.316 $187.78 41.82%
2023-02-28 7 $321 $205 $261.85 $187.78 39.45%
2023-04-12 7 $350 $230.1 $293.35 $187.78 56.22%
2023-04-25 6 $350 $262 $298.883 $187.78 59.17%
2023-05-05 6 $350 $263.3 $305.883 $187.78 62.89%
2023-05-09 6 $350 $263.3 $306.55 $187.78 63.25%
2023-06-26 6 $350 $257 $299.383 $187.78 59.43%
2023-06-30 7 $350 $196 $284.614 $187.78 51.57%
2023-07-12 7 $350 $196 $279.214 $187.78 48.69%
2023-07-17 8 $350 $196 $278.687 $187.78 48.41%
2023-08-03 8 $350 $196 $276.025 $187.78 46.99%
2023-08-04 8 $350 $196 $277.275 $187.78 47.66%
2023-08-07 8 $350 $196 $277.15 $187.78 47.59%
2023-08-17 9 $350 $196 $278.244 $187.78 48.18%
2023-09-06 8 $350 $196 $275.275 $187.78 46.59%
2023-09-12 9 $350 $196 $275.677 $187.78 46.81%
2023-09-20 9 $350 $196 $273.888 $187.78 45.86%

The Trend in the Analyst Price Target


Over the past 40 months, BGNE's average price target has gone up $83.66.

BGNE reports an average of 31.68% for its upside potential over the past 50 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-12-15 6 302 205.0 245.600 207.92 18.12%
2023-02-28 7 350 230.1 294.183 224.63 30.96%
2023-06-26 6 350 257.0 299.383 180.09 66.24%
2023-08-03 8 350 196.0 276.025 205.82 34.11%
2023-08-17 8 350 196.0 275.525 192.28 43.29%

BGNE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.44 7 0 2 0 0 9

The Trend in the Broker Recommendations


Over the past 14 months, BGNE's average broker recommendation rating improved by 0.33.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BGNE as an investment opportunity.

  • BEIGENE LTD's average analyst price target is higher than 4909.47% of all US stocks.
  • BEIGENE LTD's number of analysts covering the stock is greater than 525.32% of stocks in the large market cap category.
  • BEIGENE LTD's upside potential (average analyst target price relative to current price) is greater than 3832.76% of stocks in the large market cap category.
  • In the context of Pharmaceutical Products stocks, BEIGENE LTD's variance in analysts' estimates is lower than -1661.7% of them.

In the Pharmaceutical Products industry, GLPG, RARE, and ALKS are the three stocks most similar to BEIGENE LTD regarding the price target and analyst recommendation information presented here.

Is BGNE a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!